5 employees
Santero Therapeutics seeks to provide novel medications with fresh modes of action that combat diseases with high resistance.
2021
$8.6M
from 4 investors over 4 rounds
Santero Therapeutics raised $8.6M on June 8, 2023
Investors: -, SFPI-FPIM, SRIW and NEWTON BIOCAPITAL